U.S. Capital Wealth Advisors LLC Cuts Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

U.S. Capital Wealth Advisors LLC decreased its stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 11.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 19,710 shares of the company’s stock after selling 2,620 shares during the period. U.S. Capital Wealth Advisors LLC’s holdings in SPDR S&P Pharmaceuticals ETF were worth $847,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 36.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock worth $197,000 after acquiring an additional 1,182 shares in the last quarter. AlphaMark Advisors LLC boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 5.9% during the 3rd quarter. AlphaMark Advisors LLC now owns 6,225 shares of the company’s stock worth $276,000 after acquiring an additional 348 shares in the last quarter. Stifel Financial Corp acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter worth about $337,000. CX Institutional acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth about $438,000. Finally, First Citizens Bank & Trust Co. boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 9.5% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock worth $3,196,000 after acquiring an additional 6,227 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Performance

NYSEARCA:XPH opened at $45.07 on Wednesday. The stock has a 50-day simple moving average of $44.35 and a 200-day simple moving average of $44.45. The stock has a market cap of $218.59 million, a P/E ratio of 14.39 and a beta of 0.87. SPDR S&P Pharmaceuticals ETF has a 1 year low of $38.88 and a 1 year high of $48.76.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.